Bhanji Muna

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
10
Insider Sells Sum
$572,554.50

Insider Activity of Bhanji Muna

According to the SEC Form 4 filings, Bhanji Muna, being in a position of

  1. director at Cytokinetics, Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 2000 shares for $104,140,
    over all time since 2023-07-07, has bought 0 shares, and sold 4000 shares for $172,375.

The largest sale of all time was on 2023-06-16 and amounted to 5893 shares of Veracyte, Inc. for $155,786.

Biography of Bhanji Muna

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $217,7354100

Comparison of Insiders on Amount of Buys and Sells

2025-01-29SaleIntellia Therapeutics, Inc.
NTLA
director
265
0.0003%
$9.97$2,642-1.19%
2024-06-10SaleCytokinetics, Incorporated
CYTK
director
2,000
0.0017%
$52.07$104,140-2.88%
2024-06-10SaleVeracyte, Inc.
VCYT
director
3,870
0.0049%
$20.32$78,634+62.07%
2024-05-28SaleVeracyte, Inc.
VCYT
director
1,539
0.002%
$21.00$32,319+57.27%
2023-10-31SaleIntellia Therapeutics, Inc.
NTLA
director
265
0.0003%
$23.90$6,334-0.06%
2023-07-31SaleIntellia Therapeutics, Inc.
NTLA
director
265
0.0003%
$42.33$11,217-35.54%
2023-07-07SaleCytokinetics, Incorporated
CYTK
director
2,000
0.0021%
$34.12$68,235+41.31%
2023-07-06SaleIntellia Therapeutics, Inc.
NTLA
director
1,867
0.0021%
$39.30$73,373-28.04%
2023-06-16SaleVeracyte, Inc.
VCYT
director
5,893
0.0083%
$26.44$155,786-6.59%
2023-05-30SaleVeracyte, Inc.
VCYT
director
1,539
0.0022%
$25.91$39,875-2.8%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.